Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminorich
- Development stage
- Unknown
- Lead developer
- Stedman Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Aminorich is a marketed nutritional supplement developed and manufactured by Stedman Pharmaceuticals. It is formulated as a combination of essential amino acids, vitamins, and minerals, including biotin, carbonyl iron, cyanocobalamin (vitamin B12), folic acid, pyridoxine (vitamin B6), zinc, and various amino acids (such as L-arginine, L-glutamine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, and L-valine). Aminorich is indicated for the treatment and prevention of nutritional deficiencies, supporting protein metabolism, red blood cell formation, immune function, and overall tissue maintenance. It is available in multiple dosage forms, including oral capsules, drops, granules, liquid, and powder.
- Brand names
- Aminorich
- Other names
- Amino-acid and vitamin products
Beyond the preview
Go deeper on Aminorich.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aminorich.